Related Experiment Videos
[Triiodothyronine thyrotoxicosis in nodular toxic goiter]
Problemy Endokrinologii
|May 1, 1976
Summary
Triiodthyronine (T3) thyrotoxicosis is common in nodular toxic goiter. Standard tests often miss this condition, which presents with subtle symptoms and less weight loss than thyroxine-driven thyrotoxicosis.
Area of Science:
- Endocrinology
- Thyroid Disorders
- Internal Medicine
Context:
- Nodular toxic goiter is a common endocrine disorder.
- Thyrotoxicosis results from excessive thyroid hormone production.
- Assessing thyroid hormone levels is crucial for diagnosis and management.
Purpose:
- To evaluate the prevalence and diagnostic utility of triiodthyronine (T3) thyrotoxicosis in patients with nodular toxic goiter.
- To compare the clinical presentation and biochemical markers of T3 thyrotoxicosis with traditional thyroxine (T4) excess.
Summary:
- Serum protein-bound iodine (PBI), total thyroxine (T4), triiodthyronine (T3), coefficient of thyroxine efficacy (CTE), and thyroxine-binding capacity (TBC) were measured in 44 patients with nodular toxic goiter.
- Elevated T3 levels were found in 27/35 patients, with T3 thyrotoxicosis diagnosed in 18, characterized by high T3 with normal T4 or CTE and unchanged TBC.
- T3 thyrotoxicosis symptoms were similar to T4 thyrotoxicosis but often milder, with less frequent weight loss and a prolonged, subclinical course in many cases.
- Traditional markers (PBI, T4, CTE) were elevated in a minority of patients, failing to diagnose hyperthyroidism in many with nodular toxic goiter where T3 thyrotoxicosis is frequent.
Impact:
- Highlights the frequent occurrence of T3 thyrotoxicosis in nodular toxic goiter.
- Underscores the limitations of conventional thyroid function tests in diagnosing this specific form of hyperthyroidism.
- Suggests the need for T3 level assessment in diagnosing hyperthyroidism in nodular toxic goiter patients when standard tests are inconclusive.